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Abstract
Background: The subtype diversity of the hepatitis C virus (HCV) genotypes is unknown in Venezuela.
Methodology/Principal Findings: Partial sequencing of the NS5B region was performed in 310 isolates circulating in
patients from 1995 to 2007. In the samples collected between 2005 and 2007, HCV genotype 1 (G1) was the most common
genotype (63%), composed as expected of mainly G1a and G1b. G2 was the second most common genotype (33%), being
G2a almost absent and G2j the most frequent subtype. Sequence analysis of the core region confirmed the subtype
assignment performed within the NS5b region in 63 isolates. The complete genome sequence of G2j was obtained. G2j has
been described in France, Canada and Burkina Fasso, but it was not found in Martinique, where several subtypes of G2
circulate in the general population. Bayesian coalescence analysis indicated a most recent common ancestor (MRCA) of G2j
around 1785, before the introduction of G1b (1869) and G1a (1922). While HCV G1a and G1b experienced a growth
reduction since 1990, coincident with the time when blood testing was implemented in Venezuela, HCV G2j did not seem to
reach growth equilibrium during this period.
Conclusions/Significance: Assuming the introduction of G2j from Africa during the slave trade, the high frequency of G2j
found in Venezuela could suggest: 1- the introduction of African ethnic groups different from the ones introduced to
Martinique or 2- the occurrence of a founder effect. This study represents an in-depth analysis of the subtype diversity of
HCV in Venezuela, which is still unexplored in the Americas and deserves further studies.
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Introduction
Around 170 million persons in the world are thought to be
infected with hepatitis C virus (HCV). The highest rates of HCV
infection are found in some North African countries like Egypt,
and in the Western Pacific regions [1]. Information is scarce about
the epidemiology of hepatitis C virus (HCV) in South America.
Overall prevalence of HCV antibodies in non-Amerindian
populations from South America is around 1% [2–4]. In the
Americas, a gradient of exposure to HCV infection has been found
from rural to urban populations groups. The prevalence of this
viral infection correlates to parenteral risk of exposure, including
iatrogenic and intravenous drug abuse [5,6].
Six HCV genotypes, and a large number of subtypes in each
genotype, have been described. HCV genotypes 1, 2, and 3 have a
worldwide distribution. HCV subtypes 1a (G1a) and G1b are the
most common genotypes in the US and are also predominant in
Europe. Although HCV G2a and G2b are relatively common in
America, Europe, and Japan, subtype 2c is found commonly in
northern Italy. HCV G3a is frequent in intravenous drug abusers
in Europe and the United States. HCV G4 appears to be prevalent
in Africa and the Middle East, and G5 and G6 seem to be
confined to South Africa and Asia, respectively [7,8]. These last
genotypes are also increasingly found in other continents,
frequently associated to particular transmission routes or epide-
miological settings [9].
The low prevalence of HCV infection in many native
population groups from Latin America strongly suggests that
HCV is not autochthonous to these regions. This situation is in
contrast with the high prevalence rates and genetic diversity found
for this virus in Africa and South Eastern Asia, which might be
associated to the origin of this virus [8]. No autochthonous HCV
genotype has been described in the region, except for some South
American lineages of G1 [10] which probably emerged during
PLoS ONE | www.plosone.org 1 December 2010 | Volume 5 | Issue 12 | e14315Table 1. Primers used for amplification and sequencing of the HCV genome.
Primer Sequence Nucleotides Polarity
939P
1 ctgtgaggaactactgtctt 45–64 Sense
940P
1 ttcacgcagaaagcgtctag 63–82 Sense
209N
1 atactcgaggtgcacggtctacgagacct 321–349 Antisense
211N
1 cactctcgagcaccctatcaggcagt 288–313 Antisense
C4N accaattcatcatcatatcccaagccattcg 1290–1320 Antisense
C5P gactgctagccgagtagtgttgggtcgcgaaag 245–277 Sense
C6N cattggtcacctggtacaccccggacacgttg 926–957 Antisense
C9N cattggtcaccatgtagctggtactggtgttc 925–956 Antisense
C10N gagatgcattccccactttctcgcacgggacgcacccg 1013–1050 Antisense
693P aaybtgggyarrgtcatcg 693–711 Sense
1298P atggcntgggayatgatg 1293–1310 Sense
1598P aatggcagntggcayathaa 1590–1609 Sense
2001N tcatccangtgcanccgaacca 1986–2007 Antisense
2001P tggttcggntgcacntggatga 1986–2007 Sense
3008P tgttygacrtdaccaadtgg 3006–3024 Sense
4175P atcaatcccaacatyagractgg 4161–4183 Sense
4290P tcatmatatgcgaygartgcca 4276–4297 Sense
5045P ggcctcacacayatagaygcyca 5031–5053 Sense
5082P aggaagtgggcrtctat 5043–5059 Antisense
5930P gtngchttyaarrtcatg 5931–5948 Sense
5930N catgayyttraadgcnac 5931–5948 Antisense
6100P tggatgaayaggctyatwgcctttgc 6084–6109 Sense
6100N gcaaaggcwatragcctrttcatcca 6084–6109 Antisense
6177N gactccgbcacgtagtg 6138–6154 Antisense
6177P cactacgtgvcggagtc 6138–6154 Sense
6522P ctggcargggacmtttccyatcaa 6506–6529 Sense
6522N ctggcargggacmtttccyatcaa 6506–6529 Sense
6623N gcgccaccytccadat 6596–6611 Antisense
6712P gagttyttytcctgggtgga 6709–6728 Sense
7071P gacatggtsgatgchaa 7025–7041 Sense
7071N gacatggtsgatgchaa 7025–7041 Antisense
7670P tgctccatgtcmtactcctggac 7663–7685 Sense
7743N gtccangagtangacat 7605–7621 Antisense
7743P atgtcntactcntggac 7605–7621 Sense
8245N
1 tcraarcagcgggtatcatacgggatcccca 8245–8275 Antisense
8245P
1 tggggatcccgtatgatacccgctgyttyga 8245–8275 Sense
8276P
1 ctccacagtcactgagagcgacat 8276–8299 Sense
PR3P tatgayacccgctgytttgactc 8256–8278 Sense
hep101
1 atacccgctgctttgactc 8260–8278 Sense
hep105
1 atacctagtcatagcctccgtga 8617–8639 Antisense
hep102
1 agcatgatgttatcagctcc 8681–8700 Antisense
8580N
1 ggcggaattcctggtcatagcctccgtgaa 8557–8580 Antisense
8625N
1 gartacctrgtcatagc 8625–8641 Antisense
8645N
1 ggcggaattcctggtcatagcctccgtgaa 8616–8645 Antisense
9325N ctacrgtaagyaggagtaggc 9325–9345 Antisense
The numbers refer to the position in the sequence of a H77 G1a isolate, accession number in Genbank AF009606. Primers were obtained from the literature
1 [53,54,63]
or designed in this study.
doi:10.1371/journal.pone.0014315.t001
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(HCV) genotype distribution with time have been reported in
several countries. In Venezuela, a significant reduction of the
circulation of HCV G1b was observed in the last decade, with the
increase of circulation of G2 [11].
It is known that the subtype diversity is only fairly appreciated
by studying the 59- non-coding (59NC) region of the HCV
genome, and that the genetic analysis of a small fragment of the
NS5B region does generally reproduce the genotypic variability
found in the complete viral genome [12,13]. The subtypic
variability has been scarcely studied in Latin America. Cristina
et al. [14] found a relatively low intragenotypic diversity of HCV
genotype 1 in Latin America, compared to that observed in Africa.
Martial et al. [15] found a great diversity of genotypes, and
particularly of subtypes of G2, in the Caribbean island
Martinique. This genotype is not very prevalent in other countries
from Latin America [14,16–19].
The aim of this study was to analyze the genetic diversity of
HCV in Venezuela and to reconstruct the genetic history of the
more prevalent epidemics subtypes. An unusual subtype of G2,
G2j, was frequently found infecting Venezuelan patients. The
complete coding region of the genome was analyzed and allowed
to confirm the previous assignment of HCV G2j, which may have
been be circulating since 1785 in Venezuela.
Results
Amplification and sequencing of the NS5B region
A total of 479 sera, previously analyzed by sequencing of the 59-
NC region, were analyzed, 166 collected between 1995 and 2004
and 313 between 2005 and 2007. Using 3 nested PCR reactions
with different combinations of primers (Table 1, see Materials and
methods), NS5b region could be amplified and sequenced in 310
of them, 80/166 (48%) of samples from the first period and 230/
313 (74%) from the latest one. The efficiency of NS5B
amplification was evaluated among the samples from the second
period of time, since these sera were not subjected to multiple
freeze-thawing. HCV samples, assigned as G2b by analysis in the
59-NC region, were less frequently amplified in the NS5B region.
While 25/38 (66%) of G2b isolates could not be amplified by the
different PCR methods adopted to amplify the NS5B region, only
59/275 (21%) of isolates belonging to other genotypes or subtypes
could not be amplified (p,0.0001).
HCV subtype distribution in Venezuela
The present distribution of HCV subtypes in Venezuela was
evaluated in the samples collected between 2005 and 2007. HCV
G1 was composed as expected of mainly G1a and G1b, and one
strain belonged to G1g (Figure 1). G4 and G3 isolates belonged to
subtype d and a, respectively (Figure 1). Unexpectedly, G2a was
almost absent from Venezuelan isolates. The specimens classified
as G2a according to the analysis of the 59NC region, were indeed
mostly G2j, a subtype found previously only in Canada and
France. This subtype was very prevalent in Venezuela during the
13 years analyzed (Figure 2). Based on the analysis of the NS5B
region, and even with the bias due to the low rate of amplification
of genotype 2b isolates, the most frequent subtypes in Venezuela
were 1a, 1b and 2j, with around 37, 26 and 21% prevalence
respectively. Several other subtypes and putative subtypes of G2
were also identified (Table 2). The gender prevalence among the
HCV infected patients was 58% of males and no significant
difference was found in the gender prevalence between the 3 most
common subtypes. There was no significant difference in the mean
age of the 74 patients whose sera was analyzed between 2005 and
2007, mean age was 41 years for HCV G1a as well as G1b and 42
years for G2j.
The diversity of subtypes in G2 was confirmed by phylogenetic
analysis by Neighbor Joining method (data not shown) and
Maximum Likelihood inference (Figure 2). A total of 130
sequences of isolates from Africa, and 6 from Martinique,
available at GenBank, were included in the phylogenetic analysis.
The G2j clade was composed of 65 sequences from Venezuela, 4
from Canada and 5 from France (two of each shown in the tree).
In addition, a strain from Burkina Fasso (AF037251) was grouped
as an ancestor of the G2j strains (Figure 2).
In order to support the genotype assignment based on the NS5B
region, sequence analysis was performed on the core region for
selected isolates, confirming the subtype assignment performed
within the NS5B region in 63 of them (Figure 3). In addition, the
core sequence from a French G2j isolate grouped with the
Venezuelan sequences. In the core region, the G2j isolates
displayed an intra-subtype mean nucleotide identity of 91%,
90% with G2k and G2c sequences, the closest available from the
GenBank. A 100% concordance was found between the subtype
assignment in the NS5B and core region, implying no evidence of
recombination in the samples analyzed in these regions. A new
subtype G2s, proposed for 5 Venezuelan isolates (C104, C1281,
C1577, C1875 y C1966), is supported by the phylogenetic analysis
of three HCV genomic regions: NS5B (Figure 2), core (Figure 3)
and E1–E2 region (this last analysis not shown). In addition,
isolates C523, C1318 and C1952 may belong to unassigned
subtypes of HCV G2 (Table 2).
Complete genome analysis of G2j isolates
The first complete genomic sequence of one G2j isolate (C1292,
nt 82 to 9347, according to reference strain AF009606) and almost
complete sequence of another isolate (C1799, nt 82 to 9127,
according to reference strain AF009606) were obtained, by
sequencing 10 overlapping PCR-amplified fragments (Table 1).
The G2j Venezuelan strains clustered together, separately from
the other G2 sequences (Figure 4). Eventual genomic recombina-
tion events of G2j sequences with other genotypes or subtype 2
genomes were ruled out by Simplot analysis (data not shown). The
complete coding region of G2j isolate C1292 exhibited less than
88% amino acid identity with G2c and G2k isolates, less than 87%
with G2a ones, and 86% and 85% with G2i and G2b isolates
respectively.
To observe the degree of genetic variation along the coding
region of the HCV genome of Venezuelan G2j, we compared the
similarity index along the HCV polyprotein among strain C1292
and reference strains from major genotype 2 subtypes. A
significant degree of genetic variation can be seen among C1292
(G2j) and strains belonging to other G2 subtypes (Figure 5). This is
particularly significant in specific regions like core, E1 and NS5A
(Figure 5).
To study the variation in the rates of synonymous and non
synonymous substitutions within the C1292 polyprotein, this strain
was compared with strains from different types and subtypes.
Figure 1. Phylogenetic analysis of non G2 HCV Venezuelan strains. NS5B region (256 nt, 8302–8556). Neighbor Joining method. Isolates are
designated by their GenBank accession number, followed by their subtype assignment and country of origin. Venezuelan isolates, are numbered and
preceded by a C. Bootstrap values over 90% are shown in the tree.
doi:10.1371/journal.pone.0014315.g001
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mous ones for all pair wise comparisons (Figure 5). For that reason,
the ratio of non synonymous distance/synonymous distance (ka/ks)
is low along the whole sequence. This has usually been associated
with purifying selection acting at the level of amino acid
conservation. Although low non synonymous rates were found
throughout the polyprotein, it is possible to observe in all
comparisons an increase of non synonymous distance in the
NS5A region of the genome (Figure 5), suggesting that NS5A
region of G2j strain C1292 may have a number of non
synonymous substitutions by comparison with other G2 subtype
strains.
The NS2/NS3 cleavage sites [20] were conserved in the two
G2j isolates. The amino acids motifs surrounding these sites were
essentially similar to the ones present in the G2c isolate, except for
the presence of an Asparagine instead of an Serine in the N
terminal of the NS4a of C1799 isolate, although this substitution is
also observed in an G3b isolate [20] (data not shown). There was a
strong conservation of potential N-linked glycosylation sites in the
envelope protein as other genotypes. The E1 protein contained
four sites (positions 196, 209, 234 and 305; numbered as in strain
D10988) which are conserved among all variants. Glycosylation in
the E2 protein was more variable. The sequence of G2j predicted
ten sites (positions 417, 423, 430, 448, 534, 542, 558, 578, 627 and
649) conserved amongst C1292 and C1799 strains. An eleventh
site was found at position 477 in C1799 strain.
Due to the fact that NS5A is a critical component of HCV
replication and is involved in several cellular processes, such as
interferon resistance [21] and apoptotic regulation [22], NS5A
sequences from G2j strain C1292 was aligned with corresponding
sequences of reference strains from other G2 subtypes, in order to
observe the amino acid changes in C1292. Interestingly, amino
acid substitutions were observed in all domains of NS5A of G2j
strain C1292 (Figure 6). Unique amino acid substitutions were
found in the interferon-sensitive determining region (ISDR) and
the Protein Kinase R (PKR) interaction region of this protein by
comparison with other genotype 2 sub-types (Figure 6).
The crystal structure of a dimeric form of domain I of NS5A
(residues 33 to 202) has been recently resolved [23]. The amino
acid substitutions found in domain I of NS5A of strain C1292
isolated in Venezuela were mapped spatially in the 3D structure of
this domain of NS5A protein (Figure 7) (Protein Data Bank
accession number 3fqq) [23]. Several substitutions occur through-
out domain I of NS5A protein. Interestingly, two substitutions at
position 118 and 168 of NS5A protein map spatially close to
residues known to interact with NS4A protein (Figure 7).
Epidemic history of the most common subtypes of HCV
circulating in Venezuela
Bayesian coalescence analysis was performed on G1a, G1b and
G2j NS5B sequences from Venezuela. For each demographic and
the molecular clock models a chain lengths of 170 million were
used and sampled every 1000 states. For the 3 subtypes analyzed,
the best fitted model was the exponential growth with relaxed
molecular clock not correlated exponential. These results suggest
an exponential increase and dissemination of the 3 HCV subtypes
in Venezuela. The data for the 3 HCV subtypes was analyzed by
using the Bayesian Skyline Plot (BSP) in order to describe the
demographic history of these viral populations (Figure 8). HCV
G1a and G1b exhibited a similar epidemic history, characterized
by a logistic growth, with an initial phase of unknown duration and
low population increase, followed by a well defined phase of
exponential growth and finally an equilibrium phase. The
epidemic history of G1b precedes the one of G1a by several
decades. While the G1b population increased exponentially
between 1911 and 1986, G1a population experienced an
exponential growth between 1952 and 1990. In contrast, the
G2j population did not reach growth equilibrium during this
period.
The most recent common ancestor (MRCA) was evaluated by
using a fixed substitution rate for NS5b region of 4.1610
24
substitutions per site/month [24], which has proven to be reliable
for the reconstruction of epidemic events [25]. In addition, the
substitution rate determined from these data sets was fairly similar
to the one reported by Pybus et al. [24] (data not shown). The use
of a predetermined substitution rate allowed a more reliable
determination of the demographic parameters. MRCA of G2j was
evaluated around 1785 (Effective Sample Size, ESS 236), before
the introduction of G1a (1922, ESS 243.8) around the same time
than G1b (1869, ESS 152.1) (Table 3).
Discussion
While HCV G1 is the most prevalent genotype throughout the
Americas, the frequency of HCV G2 varies from country to
country. Although it is not very common in Brazil, Canada, Chile,
Mexico, or the USA, the HCV G2c genotype is the second most
frequently isolated, after G1 [11,14,26–30], in Argentina [17]. In
Figure 2. Phylogenetic analysis of G2 HCV Venezuelan strains. NS5B region (209 nt, 8343–8549). Maximum likelihood analysis. Isolates are
designated by their GenBank accession number, followed by their subtype assignment and country of origin. Venezuelan isolates, are numbered and
preceded by a C. Bootstrap values over 90% are shown in the tree. The arrow indicates the strain from Burkina Fasso (GenBank accession number
AF037251) which appears as an ancestor of the G2j strains.
doi:10.1371/journal.pone.0014315.g002
Table 2. HCV genotypes and subtypes distribution in
Venezuela during 2005–2007.
Subtype assigned
by NS5b region
N (% over a total 230)
(Isolates)
Genotype
distribution
1a 84(37%) 144 (63%)
1b 59(26%)
1g 1(0.4%)(C1990)
2j 48(21%) 77 (33%)
2b 14(6%)
2c 7(3%)
2a 1(0.4%)(C1726)
2r 1(0.4%)(C1170)
2s
1 4(2%)(C104,C1281,C1577,
C1875,C1966, others)
2
2
3 2(0.9%)(C523,C1318,C1952)
3a 9(4%) 9 (4%)
1: New subtype assignment proposed based on the analysis of core, E1–E2 and
NS5B genomic regions. 2: C104 sample from the 1995–2004 period not
included for prevalence determination. Others: G2s strains from Guinea-Bissau,
Burkina Fasso, Ghana, Madagascar, and Martinique. 3: Unclassified G2 subtypes.
C523 sample from the 1995–2004 period not included for prevalence
determination.
doi:10.1371/journal.pone.0014315.t002
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the past decade [11]. In the present study HCV G2 was found to
be more diverse than suspected, and more diverse than G1. A
similarly high degree of of G2 diversity was previously described in
Martinique, although the subtype distribution was different [15].
The HCV G2j subtype that predominates in Venezuela was not
found in Martinique [15], although it has been described in
France, Canada and Burkina Fasso [12,31–33]. The classification
of Venezuelan isolates as G2j was confirmed by phylogenetic
analysis in the core and E1–E2 regions, and by sequencing the
complete genome of one isolate. The complete and nearly
complete genomic sequences of G2j showed that this subtype is
different from others previously described, and has several features
that distinguish it from the closest related subtypes, G2a, G2c and
G2k. In addition, at least one new subtype of HCV G2, proposed
as 2s, was found in Venezuela. This new designation was based on
the phylogenetic analysis of at least three informative regions of
the HCV genome (core, E1–E2 and NS5B), and the presence of
the new subtype in six different isolates, 5 from Venezuela and one
from Guinea-Bissau [33].
Venezuelan strains of HCV G2 could have been introduced
into the Americas with the slave trade. Between the 15th and 19th
centuries over 11 million Africans were forcibly removed from
Africa, principally from coastal areas in West and West Central
Africa, and shipped to the Americas [34]. While it is difficult to
determine the origins of specific ethnic groups in each country [35]
it is thought that most of the slave population in Venezuela was
brought from West Africa, with a primary acclimation stay in the
Caribbean islands, particularly the Dominican Republic (Castro
de Guerra, D., personal communication). The HCV G2 diversity
found in Venezuela is compatible with its having been brought
from West Africa, where the genotype appears to have been
circulating for a long time [33]. It is interesting that one G2r
isolate, C1170, clustered together with G2r isolates infecting
Canadian immigrants from Haiti and Dominican Republic [12],
perhaps reflecting the stays of West African slaves on the island of
Hispaniola.
HCV G2 sequences are now available from several West
African countries, and their phylogenetic tree displays a spatial
structure grouped in clusters corresponding to geographic areas: 1)
Cameroon and Central African Republic, 2) Benin, Ghana and
Burkina Fasso, 3) Gambia, Guinea, Guinea-Bissau and Senegal
and 4) Madagascar [33]. The G2j sequences were grouped within
the second cluster, and one G2j related isolate was found in
Burkina Fasso. A possible origin of G2j in this former French
colony is compatible with the finding of several G2j strains in
Canada and France [12,31,36]. Although significantly less
represented than the G2j subtype, other Venezuelan G2 isolates
were related to the African clusters 1 and 3 (above), but none were
related to the Madagascar cluster. This diversity of G2 subtypes
suggests diverse geographic origins for the slaves brought to
Venezuela. Population descendants from Congo, the Democratic
Republic of Congo and Angola might have been frequent in
Venezuela. Interestingly, G2 is less frequent than G4 in Congo
and the Democratic Republic of Congo [37,38]. No information is
available for Angola. The puzzling question is how to explain the
predominance of G2j in a context where more G2 diversity would
be expected, but this could represent a founder effect [39] of G2j
in Venezuela.
Bayesian coalescence analysis indicated an MRCA of G2j in
Venezuela around 1785, very close to the MRCA of G2c in
France (1791) [40]. This considerably predates the MRCA’s for
G1b in Venezuela (1869), which is similar to that in Brazil, Chile
and US [41–43] but older than reported in Argentina and China
(1964–1979) [44,45], and G1a (1922), which is similar to that in
Brazil and US [42,45]. Interestingly, the epidemic history of G2j is
also distinct from that of the G1 subtypes. While the G1 strains
displayed an exponential growth through 1985–1990, before
reaching a plateau coincident with the implementation of HCV
blood bank testing in Venezuela in 1994 [11], the G2j strains do
not seem to have reached growth equilibrium during this period.
Some of the HCV epidemics have been associated with
particular transmission routes, such as intravenous drug use in
the case of HCV G3a [46], and parenteral treatment of
schistosomiasis with G4 in Egypt [47]. Sexual transmission of
HCV seems to occur but is thought to be infrequent [48,49]. A
recent study, however, suggests that sexual transmission might
have played an important role in the transmission of HCV G2
over the past centuries in Guinea Bissau, where this genotype is
highly predominant [50]. Although there is no evidence that a
particular variant of HCV might be more efficiently transmitted
by a specific route, this issue has not been addressed adequately. It
has been shown that HIV co-infection could be an important
factor contributing to an efficient sexual transmission of HCV in
African countries [51,52]. It is not known if sexual transmission
might play a role in the dissemination of G2j in Venezuela.
In conclusion, an unexpected HCV variant, G2j, was found at a
relatively high frequency in Venezuela, and could have been
introduced into the country with slaves from West Africa. The
almost complete genome sequences of two strains confirmed its
classification as a distinct subtype within G2. This study represents
an in-depth analysis of the subtype diversity of HCV in Venezuela.
HCV subtype diversity is still unexplored in the Americas and
deserves further studies.
Materials and Methods
This study was approved by the Bioethical Committee of
Instituto Venezolano de Investigaciones Cientificas (IVIC). Serum
samples were collected after written informed consent of the
patients.
PCR and sequencing
HCV genotype was determined by direct sequencing (Macro-
gen Service Center, Seoul, Korea) of a PCR-amplified product
from the NS5B region. In order to maximize the probability of
amplifying the NS5b region, the NS5b amplicon was generated by
either one of three combinations of RT-nested PCR using: primers
hep101-hep102 and primers hep101-hep105 in the first and
second round [53], primers 8245P-8645N and 8276P-8580N in
the first and second round [54] or a combination of these primers
8245P-hep102 and 8245P-8645N in the first and second round.
Genotype was also previously assigned to these samples by
sequencing the PCR product of the 59NC region [11]. Core
region was amplified by RT-nested PCR with primers 939P-C4N
for the first round and combinations of C5P with C4N, C6N or
C9N, in order to maximize the success in amplification (Table 1).
Both sense and antisense inner primers were used for sequencing.
Figure 3. Phylogenetic analysis of HCV Venezuelan strains in the Core region (507 nt, 372–877). Maximum likelihood analysis. Isolates are
designated by their GenBank accession number, followed by their subtype assignment and country of origin. Venezuelan isolates, are numbered and preceded
by a C. Bootstrap values over 90% are shown in the tree.
doi:10.1371/journal.pone.0014315.g003
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genome of G2j isolates, in regions exhibiting either conservation
among G2 isolates. A total of 10 PCR overlapping fragments were
sequenced, using primers described in Table 1:
N Fragment 1: 939P-C4N (1275nt), sequenced with primers
939P, C4N, C5P and 693P.
N Fragment 2: first round 939P-2001N, and second round either
693P-2001N for strain C1799 and 1298P-2001N for C1298,
sequenced with primers 693P, 1298P, C4N, 2001N.
N Fragment 3: first round 2001P-3765N, and second round
2001P-3462N, sequenced with primers 2001P, 2451N, 2533P,
2533N, 3008N, 3105P, 3462N.
N Fragment 4: first round 2001P-5082N, and second round
3008P-5082N, sequenced with primers 3008P, 3185P, 4175P,
4175N, 4290P, 4290N, 3462N, 5082N.
N Fragment 5: first round 2001P-5930N, and second round
4175P-5309N, sequenced with primers 4175P, 5045P, 5045N,
5082P, 5082N, 5309N.
N Fragment 6: first round 2001P-6623N, and second round
5045P-6623N, sequenced with primers 5045P, 5930P, 5930N,
6100P, 6100N, 6522N, 6623N.
N Fragment 7: 5930P-7071N, sequenced with sense and
antisense primers.
N Fragment 8: only for isolate C1799, first round 5930P-8645N,
and second round 6712P-8625N, sequenced with primers
6712P, 7071P, 7071N, 7743P, PR3P, 8625N).
N Fragment 9: first round 5082P-102N, and second round
5930P-8645N, sequenced with primers 5930P, 6522P, 7071P,
7071N, 7670P, 7743P, 8245N, 8645N, for C1292 isolate. –
Fragment 10: first round 7743P-9325N, and second round
8245P-9325N for C1799 and PR3P-9325N for C1292, both
sequenced with primers 8245P, 8276P, 8645N, 9325N.
Phylogenetic analysis
Sequence alignment was performed by the global alignment
algorithm, using DNAman 5.2.2 (Lynnon Bio Soft, Canada).
Figure 4. Phylogenetic analysis of G2j HCV Venezuelan complete genome strains. Almost complete genome (9046 nt, 82–9127).
Maximum likelihood analysis. Reference isolates are designated by their GenBank accession number, followed by their subtype assignment and
country of origin. Venezuelan isolates are shown in bold. Bootstrap values over 90% are shown in the tree.
doi:10.1371/journal.pone.0014315.g004
Figure 5. Profiles of synonymous and non synonymous distances between Venezuelan G2j strain C1292 and HCV strains from
other G2 subtypes along the HCV polyprotein(9036 nt, 342–9374). Synonymous substitutions are shown by blue line (Ks) and non-
synonymous substitutions by a red line (Ka). Comparison of sequences from C1292 strain and strains D00944 (G2a) (A); D10988 (G2b) (B); D50409
(G2c) (C) and AB032663 (G2k) (D). The x-axis depicts the coding nucleotide position number in the middle of the window, and the y-axis depicts
distance. NS5A region is indicated by a bracket.
doi:10.1371/journal.pone.0014315.g005
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PLoS ONE | www.plosone.org 10 December 2010 | Volume 5 | Issue 12 | e14315Phylogenetic analysis was performed either by the Neighbor
Joining method (1000 bootstrap replicas, with genetic distances
evaluated with Kimura 2 parameters corrections) (DNAman 5.2.2,
Lynnon Bio Soft, Canada) or by Maximum Likelihood analysis,
using the program PhyML version 3. Approximate Likelihood
Ratio Test (aLRT) and the best-fit model analyzed here was
selected with the Akaike Information Criterion (AIC) by using
Modeltest Version 3.06 [55]: GTR model of substitution (4
Gamma rate categories). Newick trees application from Mega
program was used for tree representation.
Recombination analysis
Complete genome sequences were aligned and tested for
possible recombination events involving sequences used in this
study. We used two approaches implemented in the SimPlot
program [56]: 1) a sliding window analysis of distances and 2) the
bootscanning [57]. The SimPlot program was also used for
establishing the similarity indexes along the HCV polyprotein.
Substitution rate analysis
The substitution rate along the HCV polyprotein was measured
using a sliding window by the procedure of Alvarez-Valin et al. [58].
Pairwise nucleotide distances (synonymous and non synonymous)
within each window were estimated by the method of Comeron [59],
as implemented in the computer program k-estimator (version 6.1),
where k is the number of nucleotide substitutions between sequences.
For those windows where this method could not be applied, the
Jukes-Cantor [60] method was used for correction for multiple hits.
The window had a size of 150 codons and a movement of 30.
NS5A 3D protein structure prediction
The crystallographic structure of the NS5A protein from HCV
genotype 2j strains is currently unknown. In order to model a 3D struc-
ture, we employed the most approximate structure available. For these
reasons, crystallography data from NS5A domain I (amino acids 33 to
202) of HCV genotype 1b [23] was imported from PDB (accession
number 3fgg), using the PDB ProteinWorkshop 3.6 program [61].
Figure 6. Alignment of complete NS5A amino acid sequences from Venezuelan G2j strain C1292 and G2 reference strains (1338 nt,
6258–7595). Strains are indicated by accession numbers for the reference strains and their subtype is indicated between parentheses. Amino acid
sequences are indicated by the one-letter code. Identity to C1292 strain is indicated by a dash. The interferon-sensitivity determining region (ISDR) is
indicated in blue, the V3 region is indicated in green. NS5A region interacting with NS4A is shown in yellow. The region interacting with PKR is shown
underlined. Major phosphorilation site is shown in red and indicated by an arrow, serine residues required for hyperphosphorilation are shown in red.
Other regions suggested to be under selective pressure during therapy are shown in grey. Substitutions found in C1292 are shown in bold and their
position is indicated by numbers at the top of the alignment.
doi:10.1371/journal.pone.0014315.g006
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PLoS ONE | www.plosone.org 11 December 2010 | Volume 5 | Issue 12 | e14315Figure 7. 3D model of domain I of NS5A protein. A dimeric model of domain I NS5A protein (PDB accession number 3FQQ) is shown. The
molecules are colored according to conformational type (turn is shown in light blue, coil in light red, helix in green and strand in blue). Amino acid
positions corresponding to NS4A interactions are shown in space filling representation in yellow. Amino acid substitution positions found in C1292
(G2j) are shown in space filling representation in grey and their positions are indicated by numbers and shown by arrows. Red arrows indicate
residues spatially close to those known to interact with NS4A protein. Two views of the molecules, rotated under the x-axis are shown in (A) and (B),
respectively.
doi:10.1371/journal.pone.0014315.g007
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Divergence times were estimated using Bayesian MCMC
(Markov Chain Monte Carlo) analysis implemented in the BEAST
program (http://evolve.zoo.ox.ac.uk/beast/) [62]. For this anal-
ysis, five population dynamics models were used: Bayesian,
constant, exponential, expansion and logistic, using Akaike’s
Information Criterion to determine the model that best fits the
data. Both strict and relaxed molecular clocks were employed to
Figure 8. Bayesian Skyline plot analysis of Venezuelan HCV isolates. G1a (A), G1b (B) and G2j (C) isolates. Solid line represents the estimation
of effective size number and shaded area the 95% confidence limit of HPD (High Population Density).
doi:10.1371/journal.pone.0014315.g008
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PLoS ONE | www.plosone.org 13 December 2010 | Volume 5 | Issue 12 | e14315explore the extent of rate variation in the data as well as the age of
the most recent common ancestor (MRCA). In all cases, the GTR
model of nucleotide substitution was used with chain lengths of
170 million with the extent of convergence assessed using the
Tracer program (http://evolve.zoo.ox.ac.uk/beast/). This analysis
was run on three different data sets of NS5b sequences: genotype
1a (n=94, 256 nt, 8301–8556), genotype 1b (n=90, 256 nt,
8301–8556), genotype 2j (n=62, 315 nt, 8301–8600).
Statistical differences were evaluated by the chi square test with
Yate’s correction, according to a computerized Epi Info program,
version 3.3.2 (Centers for Disease Control and Prevention,
Atlanta, GA, USA). The GenBank/EMBL/DDBJ accession
numbers of the sequences reported in this paper are
HM777048-HM777450, GU054427, GU054422, GU054421,
GU054389, and GU054385.
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